Marketing-authorisation holder · Brazil
Equilibrio Comercio de Produtos Farmaceuticos Ltda
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABEVMY | Bevacizumab | Brazil | Cancelled | 2023 |
| Fulphila | Pegfilgrastim | Brazil | Cancelled | 2023 |
| HULIO | Adalimumab | Brazil | Cancelled | 2023 |
| KIRSTY | Insulin aspart | Brazil | Cancelled | 2024 |
| NEPEXTO | Etanercept | Brazil | Cancelled | 2023 |
| SEMGLEE | Insulin glargine | Brazil | Cancelled | 2023 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 6 |